Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Zenas BioPharma (ZBIO) over the last 2 years, with Q3 2025 value amounting to $40.0 million.

  • Zenas BioPharma's Cash from Investing Activities rose 24963.75% to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$162.3 million, marking a year-over-year change of. This contributed to the annual value of -$30.6 million for FY2024, which is 17961764.71% down from last year.
  • Latest data reveals that Zenas BioPharma reported Cash from Investing Activities of $40.0 million as of Q3 2025, which was up 24963.75% from -$112.3 million recorded in Q2 2025.
  • Zenas BioPharma's Cash from Investing Activities' 5-year high stood at $40.0 million during Q3 2025, with a 5-year trough of -$112.3 million in Q2 2025.